Magnolia Capital Advisors’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
RSCM
Magnolia Capital Advisors's AGL Position: Q1 2022 in Review
Magnolia Capital Advisors sold out of Agilon Health (AGL) in Q1 2022, closing a stake of 304 shares — an estimated $205K sold.
Magnolia Capital Advisors first reported a position in AGL in Q4 2021 and held it in 1 quarter. The position peaked at $205K in Q4 2021. 121 funds tracked by Wall St. Rank hold AGL as of Q1 2022.
- Magnolia Capital Advisors reported no remaining Agilon Health position as of Q1 2022 after selling out during the quarter.
- Magnolia Capital Advisors sold 304 Agilon Health shares in Q1 2022, an estimated $205K.
- Magnolia Capital Advisors first reported a position in Agilon Health in Q4 2021 and held it in 1 quarter.
- Magnolia Capital Advisors's Agilon Health position peaked at $205K in Q4 2021.
- 121 funds tracked by Wall St. Rank held Agilon Health as of Q1 2022.
Based on Magnolia Capital Advisors's 13F filing for Q1 2022, filed 16 May 2022.